DataMeds AI, Inc.

MEDS Nasdaq SEC CIK 2030763
Follow DataMeds AI Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $2.7M −11.4% vs same quarter last year
Net income $10.6M +130.9% vs same quarter last year
EPS, diluted $2.72 +111.8% vs same quarter last year
Operating cash flow −$2.9M −155.7% vs same quarter last year
Revenue by quarter
$12.4M
$10.9M
$7.8M
$3M
$1.7M
$1.6M
$1.8M
$2.7M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income4 fiscal years
−$150M−$100M−$50M$0FY22FY23FY24FY25
Show the numbers
YearNet income
FY25−$101.3M
FY24−$6.9M
FY23−$2.9M
FY22-